Scholar Rock is seeking an experienced and motivated Senior Director, Commercial Quality / Market Quality (Switzerland) to build and lead a phase-appropriate, scalable, and inspection-ready Commercial Quality function as Scholar Rock advances to and expands in commercial supply. Reporting to the Head of Global Quality, this role is the Quality leader accountable for establishing clear separation between manufacturing control and commercial control through creation of a dedicated Market Release Authorization vertical, ensuring compliant disposition for each market and reliable supply to patients.
Based in Switzerland, the Senior Director, Commercial Quality is accountable for EU/EEA-aligned commercial quality governance, including oversight of QP certification and market release readiness (where applicable), and for establishing the authority to place and lift commercial holds (including for safety, distribution, shortage mitigation, and recall/field action reasons). This leader will create robust post-market controls that meet FDA, European/Swiss expectations (and ROW in market requirements) to ensure compliant product release, complaint handling, investigations/CAPA, and effective management of quality risks in the marketplace.
Position Responsibilities
- Provide senior leadership for Commercial Quality, ensuring patient-focused, compliant, and robust oversight of marketed product(s) and launch readiness for new indications/markets.
- Establish and own the Market Release Authorization vertical, distinguishing manufacturing batch disposition from commercial/market disposition and ensuring release decisions meet applicable market requirements (U.S., EU, and other regions as expanded).
- Serve as the end-to-end Quality leader for commercial operations, partnering with Supply Chain, Distribution/Logistics, Labeling, Regulatory, Pharmacovigilance, Medical Affairs, and Manufacturing/CMOs to enable reliable supply and compliant market execution.
- Hold decision rights to place and lift commercial holds, including for safety signals, distribution excursions, labeling issues, complaint trends, shortage mitigation, or recall-related actions; ensure clear governance, escalation pathways, and documentation.
- Own and continuously improve the post-market quality system to meet health authority expectations as per applicable guidance, and to support global regulatory commitments.
- Lead commercial product release/disposition governance, including product status control, release documentation, country-specific requirements, and oversight of release by Qualified Person (QP) (as applicable), governance of batch certification packages and escalation pathways for quality decisions.
- Provide Quality oversight for distribution and logistics, including EU GDP expectations, temperature-controlled/cold chain processes, lane qualification, distribution excursions/investigations, returns/destruction, and oversight of 3PLs and other service providers across Switzerland, EU/EEA, and other regions through quality agreements and metrics.
- Lead commercial Quality inspection readiness and external interactions, including health authority inspections, ensuring sustained compliance across the commercial supply chain.
- Lead and execute recall and field action readiness and response (including mock recalls), partnering with PV/Medical/Regulatory and Supply Chain to ensure timely decisions, effective communications, and compliant execution (including EU/UK-style Field Safety Corrective Actions where applicable).
- Oversee quality impact assessment and decision-making for changes that may affect marketed product (process, analytical, specifications, site/supplier, packaging/labeling, distribution lanes), ensuring alignment with filings/commitments and market release requirements.
- Provide governance for commercial packaging and labeling quality (artwork/label content controls, printed component release, reconciliation, tamper evidence), and partner with Regulatory Labeling to ensure compliant implementation across markets.
- Partner with Supply Chain/IT and external providers to ensure compliance with applicable serialization/traceability requirements and robust product security controls, as needed by market.
Candidate Requirements
- BS/BA degree in a scientific or engineering discipline required; advanced degree preferred
- 15+ years of progressive Quality experience in biotech/pharma (biologics preferred), including significant leadership of commercial quality and oversight of external manufacturing, packaging/labeling, testing, and distribution networks; people leadership strongly preferred
- Demonstrated expertise with marketed product quality systems, including commercial batch release/market disposition, product status control, complaint handling, and quality risk management
- Strong working knowledge of European and Swissmedic regulations and guidance applicable to commercial supply; experience representing Quality in health authority inspections (e.g., EMA member state authorities, MHRA, Swissmedic, FDA)
- Hands-on experience operating within an EU/EEA commercial release model, including governance of QP certification activities and batch certification packages; prior direct QP qualification is a plus
- Experience establishing and governing post-market product monitoring, including complaint trending and signal detection interfaces with Pharmacovigilance/Medical, management review/KPIs, and continuous improvement
- Proven experience leading recalls/field actions, including decision-making, health authority notifications support, cross-functional execution, and effectiveness checks; experience conducting mock recalls preferred
- Demonstrated ability to lead through influence in a matrixed organization and drive effective governance across external partners (e.g., quality agreements, release expectations, GDP oversight, metrics/KPIs, escalation pathways, and performance improvement)
- Strong executive presence and communication skills, sound risk-based judgment, and the ability to balance strategic leadership with timely, compliant quality decision-making
- Highly proactive, decisive, and capable of independently driving complex cross-functional initiatives in a fast-paced environment; experience scaling commercial quality capabilities for European launch and expansion (including GDP networks and QP release models) and broader ex-U.S./ROW expansion strongly preferred
Skills Required
- BS/BA degree in a scientific or engineering discipline
- Advanced degree in relevant field
- 15+ years progressive Quality experience in biotech/pharma, biologics preferred
- Significant leadership of commercial quality and oversight of external manufacturing, packaging/labeling, testing, and distribution networks
- People leadership experience
- Demonstrated expertise with marketed product quality systems including commercial batch release, market disposition, product status control, complaint handling, and quality risk management
- Strong working knowledge of European and Swissmedic regulations and health authority expectations; experience with inspections (EMA member state, MHRA, Swissmedic, FDA)
- Hands-on experience with EU/EEA commercial release model, governance of QP certification activities and batch certification packages
- Direct QP qualification
- Experience establishing post-market monitoring, complaint trending, signal interfaces with Pharmacovigilance/Medical, and KPI-driven continuous improvement
- Proven experience leading recalls/field actions, including health authority notifications and mock recalls
- Experience scaling commercial quality capabilities for European launch, GDP networks, and ROW expansion
- Strong executive presence, communication skills, risk-based judgment, and ability to drive cross-functional governance
- Experience overseeing distribution/logistics quality (GDP, cold chain, lane qualification, 3PL oversight)
- Ability to partner with Supply Chain, Regulatory, PV, Medical Affairs, and Manufacturing/CMOs
What We Do
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy









